FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martin, A.
Right arrow Articles by Tsui, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martin, A.
Right arrow Articles by Tsui, F. W.

The FASEB Journal, Vol 9, 1226-1233, Copyright © 1995 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Epitope studies indicate that histidyl-tRNA synthetase is a stimulating antigen in idiopathic myositis [published erratum appears in FASEB J 1995 Nov;9(14):1496]

A Martin, MJ Shulman and FW Tsui
Department of Immunology, University of Toronto, Ontario, Canada.

The most frequently found myositis-specific antibody, the anti-Jo-1 antibody (anti-HRS), binds to histidyl-tRNA synthetase (HRS). Although this antibody reacts with HRS, it is unclear whether HRS is the stimulating antigen or is merely a protein that cross-reacts with a yet undefined antigen. Because antibody directed against an unrelated antigen would not be expected to cross-react with HRS at multiple sites, we mapped the epitopes on HRS to resolve this issue. We found by Western blot analyses that immunoglobulins G (IgG) from 18 of 19 anti- HRS positive patient sera react with amino acids 2-44 and 286-509 of HRS. Patient IgG specific for these two epitopes were found not to inhibit HRS enzyme activity. Instead, the inhibitory property of anti- HRS was found to be associated with antibodies that do not react to HRS in immunoblots, indicating the presence of other epitopes. In addition, antibodies that react in immunoblots were found to represent only a small fraction of total anti-HRS antibody. Our finding that patient IgG recognized at least three distinct epitopes on HRS strongly suggests that the immunological response at some point in the disease is directed against HRS and not against a cross-reactive antigen.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
D. P. Ascherman, T. B. Oriss, C. V. Oddis, and T. M. Wright
Critical Requirement for Professional APCs in Eliciting T Cell Responses to Novel Fragments of Histidyl-tRNA Synthetase (Jo-1) in Jo-1 Antibody-Positive Polymyositis
J. Immunol., December 15, 2002; 169(12): 7127 - 7134.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Martin, H. W. Tsui, M. J. Shulman, D. Isenman, and F. W. L. Tsui
Murine SHP-1 Splice Variants with Altered Src Homology 2 (SH2) Domains. IMPLICATIONS FOR THE SH2-MEDIATED INTRAMOLECULAR REGULATION OF SHP-1
J. Biol. Chem., July 30, 1999; 274(31): 21725 - 21734.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by The Federation of American Societies for Experimental Biology.